查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1934995

皮膚鏡市場 - 全球產業規模、佔有率、趨勢、機會及預測（按產品、技術、模式、應用、最終用戶、地區和競爭格局分類），2021-2031年

Dermatoscope Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product, By Technology, By Modality, By Application, By End User, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 182 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球皮膚鏡市場預計將從 2025 年的 9.6791 億美元成長到 2031 年的 19.5031 億美元，複合年成長率為 12.39%。

皮膚鏡是一種非侵入性、攜帶式醫療設備，它利用特定的照明和放大技術來觀察深層皮膚結構，從而能夠對病灶進行精確分析，用於診斷。市場成長的主要驅動力是全球皮膚癌發病率的上升以及人們越來越重視早期檢測以提高患者康復率。此外，由於需要進行準確的非手術評估，皮膚鏡在遠距皮膚科會診和全科診療中的應用日益廣泛，也推動了該設備在醫療保健網路中的普及。

市場概覽
預測期 2027-2031
市場規模：2025年 9.6791億美元
市場規模：2031年 19.5031億美元
複合年成長率：2026-2031年 12.39%
成長最快的細分市場 接觸式皮膚鏡
最大的市場 北美洲

根據美國癌症協會估計，2024年美國將新增100,640例侵襲性黑色素瘤病例，凸顯了日益嚴重的疾病負擔，亟需有效的診斷解決方案。儘管需求迫切，但先進數位皮膚病系統的高昂以金額為準仍然是一大障礙。這項經濟負擔限制了發展中地區和小規模診所的購買能力，可能阻礙全球皮膚病學市場的廣泛擴張和普及。

市場促進因素

人工智慧 (AI) 與皮膚病學的融合正在從根本上改變這一領域，它提高了診斷準確率，並最大限度地減少了對主觀臨床評估的依賴。將 AI 演算法與數位皮膚鏡結合，使醫療專業人員能夠以極高的精度分析病變的頻譜模式，從而實現快速的臨床決策。這項技術變革得益於近期監管方面的進展。例如，DermaSensor 在 2024 年 1 月的新聞稿中宣布其 AI 驅動的醫療設備獲得 FDA 批准，並公佈了關鍵研究結果，表明其光譜設備在 224 例皮膚癌病例中達到了 96% 的靈敏度，顯著高於標準基層醫療的檢出率。此類進展對於簡化轉診流程以及將皮膚病學工具的效用擴展到專科診所之外至關重要。

同時，全球皮膚癌和黑色素瘤發病率的持續上升推動了先進診斷設備的應用。惡性病變發生率的增加，使得廣泛篩檢計畫和採用高性能皮膚鏡以確保早期療育尤為必要。為了說明這個長期趨勢，美國國家皮膚癌基金會在2025年1月發布的報告顯示，2015年至2025年間，美國每年新增侵襲性黑色素瘤病例數增加了42%。這種激增不僅限於北美，也加劇了國際疾病負擔。根據世界衛生組織（世衛組織）2024年2月發布的全球癌症觀察資料庫，2022年全球約有331,722例新增皮膚黑色素瘤病例，凸顯了全球普及診斷基礎設施的迫切需求。

市場挑戰

數位皮膚鏡系統的高昂部署成本是全球皮膚鏡市場擴張的一大障礙。這一經濟障礙限制了市場准入，尤其對於資本支出受到嚴格控制的發展中地區的小規模私人診所和醫療機構而言更是如此。當診斷設備的初始投資超出這些診所有限的預算時，部署往往會被推遲或取消，這直接導致銷售下降，並減緩了技術的普及速度。

醫療產業的經濟壓力進一步加劇了這個問題，限制了可用於設備現代化的資金。正如美國醫學會指出的，聯邦醫療保險醫師收費標準轉換係數將於2024年下降3.37%，這將給醫療機構帶來額外的財務壓力。報銷水準的降低減少了醫生可用於購買高成本設備的資金。因此，小規模企業無力承擔這些成本，阻礙了市場在成本敏感型細分領域充分發揮其潛力。

市場趨勢

遠距皮膚科會診和遠距離診斷平台的興起正成為應對醫療系統不堪重負的患者數量的關鍵手段。由於皮膚科長期面臨人員短缺，遠距分診模式無需即時進行面對面會診即可快速評估皮膚病變，從而有效地優先處理高風險患者。這種營運模式的轉變源自於簡化臨床工作流程和縮短惡性腫瘤評估等待時間的迫切需求。這項需求規模龐大：如同2025年5月《藥學論壇》（Pharmaphorum）一篇關於人工智慧支援英國國家醫療服務體系（NHS）的報導所指出的，英國皮膚科服務每年收到約100萬例基層醫療轉診，由此產生的瓶頸需要可擴展的數位化路徑來應對。

同時，基於雲端的圖像儲存和連接解決方案的出現正在推動該行業基礎設施的現代化，使市場從獨立硬體轉向整合診斷生態系統。製造商和軟體開發人員正大力投資建立平台，以實現全科醫生和專科醫生之間的無縫數據傳輸，從而使高品質的皮膚鏡圖像能夠透過去中心化網路即時存取。積極的資金籌措活動也印證了這一商業性發展趨勢，這些活動旨在擴展數位化能力。根據HTN 2025年4月發布的報告，SkinAnalytics在資金籌措，用於擴展其雲端連接診斷產品，並進軍醫療人員短缺的國際市場。

目錄

第1章概述

第2章調查方法

第3章執行摘要

第4章：客戶評價

第5章 全球皮膚鏡市場展望

  • 市場規模及預測
    • 按金額
  • 市佔率及預測
    • 依產品分類（接觸式皮膚鏡、混合式皮膚鏡、非接觸式皮膚鏡）
    • 依技術（LED、氙氣、鹵素、紫外線）
    • 依使用方式（手持式、推車式、頭戴式）
    • 外用（皮膚腫瘤、黴菌感染疾病、疣、疥瘡等）
    • 依最終使用者（皮膚科診所、醫院等）分類
    • 按地區
    • 按公司（2025 年）
  • 市場地圖

第6章 北美皮膚鏡市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國家分析
    • 美國
    • 加拿大
    • 墨西哥

7. 歐洲皮膚鏡市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國家分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

8. 亞太地區皮膚鏡市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

9. 中東和非洲皮膚鏡市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東和非洲：國家分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章：南美洲皮膚鏡市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國家分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章 市場動態

  • 促進要素
  • 任務

第12章 市場趨勢與發展

  • 併購
  • 產品發布
  • 最新進展

第13章 全球皮膚鏡市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的可能性
  • 供應商電力
  • 顧客權力
  • 替代品的威脅

第15章 競爭格局

  • Canfield Scientific, Inc.
  • FotoFinder Systems, Inc.
  • HEINE Optotechnik GmbH & Co. KG
  • Caliber Imaging & Diagnostics, Inc.
  • ILLUCO Corporation Ltd.
  • Bio-Therapeutic, Inc.
  • Optilia Instruments AB
  • Rudolf Riester GmbH
  • NIDEK CO., LTD.
  • KIRCHNER & WILHELM GmbH+Co. KG

第16章 策略建議

第17章：關於研究公司及免責聲明

簡介目錄
Product Code: 12866

The Global Dermatoscope Market is projected to experience substantial growth, expanding from a value of USD 967.91 Million in 2025 to USD 1950.31 Million by 2031, representing a Compound Annual Growth Rate (CAGR) of 12.39%. Defined as a non-invasive, handheld medical instrument, a dermatoscope employs specific illumination and magnification techniques to visualize subsurface skin structures, allowing for the precise analysis of lesions for diagnostic purposes. The market's upward trajectory is primarily driven by the increasing global incidence of skin cancer and a heightened focus on early detection to enhance patient recovery rates. Furthermore, the broadening application of dermoscopy within tele-dermatology and general practice facilitates greater device adoption across healthcare networks, fueled by the necessity for accurate, non-surgical assessments.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 967.91 Million
Market Size 2031USD 1950.31 Million
CAGR 2026-203112.39%
Fastest Growing SegmentContact Dermatoscope
Largest MarketNorth America

According to the American Cancer Society, estimates for 2024 indicated that 100,640 new cases of invasive melanoma would be diagnosed in the United States, highlighting the intensifying disease burden that demands effective diagnostic solutions. Despite this critical need, a notable obstacle remains regarding the high expense associated with advanced digital dermatoscopy systems. This financial hurdle restricts purchasing capabilities in developing regions and smaller clinics, which could potentially impede the widespread expansion and penetration of the Global Dermatoscope Market.

Market Driver

The integration of artificial intelligence into dermatoscopy is fundamentally transforming the sector by improving diagnostic accuracy and minimizing reliance on subjective clinical evaluations. By pairing AI algorithms with digital dermatoscopes, practitioners can analyze lesion spectral patterns with exceptional precision, thereby enabling prompt clinical decision-making. This technological shift is validated by recent regulatory achievements; for instance, DermaSensor Inc. announced in a January 2024 press release regarding FDA clearance for an AI-powered medical device that a pivotal study showed their spectroscopy device achieved a 96 percent sensitivity rate across 224 identified skin cancers, significantly surpassing standard primary care detection rates. These advancements are essential for streamlining referral processes and extending the utility of dermatoscopic tools beyond specialized clinics.

Simultaneously, the rising global prevalence of skin cancer and melanoma acts as a continuous catalyst for the acquisition of sophisticated diagnostic instruments. The escalating frequency of malignant lesions requires widespread screening programs and the adoption of high-performance dermatoscopes to ensure early intervention. Illustrating this long-term trend, The Skin Cancer Foundation reported in January 2025 that the number of new invasive melanoma cases diagnosed annually in the United States rose by 42 percent between 2015 and 2025. This surge extends beyond North America, as the disease burden grows internationally; according to the World Health Organization's February 2024 'Global Cancer Observatory' database, approximately 331,722 new cases of cutaneous melanoma were diagnosed globally in 2022, underscoring the urgent worldwide need for accessible diagnostic infrastructure.

Market Challenge

The substantial cost required to acquire digital dermatoscopy systems serves as a significant restraint on the expansion of the Global Dermatoscope Market. This financial barrier limits market access, particularly for smaller private practices and healthcare facilities in developing regions where capital expenditure is tightly controlled. When the upfront investment for diagnostic instrumentation exceeds the limited budgets of these clinics, procurement is often postponed or cancelled, which directly reduces the volume of unit sales and slows the rate of technology adoption.

Economic pressures within the broader healthcare industry further exacerbate this issue by restricting the funds available for equipment modernization. As noted by the American Medical Association, the conversion factor for the Medicare Physician Fee Schedule was reduced by 3.37 percent in 2024, placing additional financial strain on medical practices. This contraction in reimbursement levels diminishes the disposable capital that physicians can allocate toward high-cost devices. Consequently, the inability of smaller entities to absorb these expenses prevents the market from reaching its full potential in cost-sensitive segments.

Market Trends

The growth of teledermatology and remote diagnostic platforms is becoming a vital mechanism for managing the excessive volume of patient cases overwhelming healthcare systems. With dermatology departments facing chronic workforce shortages, remote triage models allow for the rapid assessment of skin lesions without the need for immediate face-to-face consultations, thereby effectively prioritizing high-risk patients. This operational shift is driven by the urgent necessity to streamline clinical workflows and reduce wait times for malignancy assessments. The scale of this demand is substantial; as highlighted in a May 2025 Pharmaphorum article regarding AI support for the NHS, dermatology services in the United Kingdom receive approximately one million referrals annually from primary care, creating a bottleneck that necessitates scalable digital pathways.

Concurrently, the emergence of cloud-based image storage and connectivity solutions is modernizing the sector's infrastructure, moving the market from standalone hardware toward integrated diagnostic ecosystems. Manufacturers and software developers are securing significant capital to build platforms that facilitate seamless data transfer between general practitioners and specialists, ensuring that high-quality dermatoscopic images are instantly accessible across distributed networks. This commercial trajectory is evidenced by robust financial activity aimed at scaling these digital capabilities; according to an April 2025 report by HTN, Skin Analytics raised £15 million in Series B funding to expand its cloud-connected diagnostic product offerings and extend its reach into international markets struggling with practitioner scarcity.

Key Market Players

  • Canfield Scientific, Inc.
  • FotoFinder Systems, Inc.
  • HEINE Optotechnik GmbH & Co. KG
  • Caliber Imaging & Diagnostics, Inc.
  • ILLUCO Corporation Ltd.
  • Bio-Therapeutic, Inc.
  • Optilia Instruments AB
  • Rudolf Riester GmbH
  • NIDEK CO., LTD.
  • KIRCHNER & WILHELM GmbH + Co. KG

Report Scope

In this report, the Global Dermatoscope Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Dermatoscope Market, By Product

  • Contact Dermatoscope
  • Hybrid Dermatoscope
  • Noncontact Dermatoscope

Dermatoscope Market, By Technology

  • LED
  • Xenon
  • Halogen
  • Ultraviolet

Dermatoscope Market, By Modality

  • Handheld
  • Trolley Mounted
  • Headband

Dermatoscope Market, By Application

  • Skin Tumors
  • Fungal Infections
  • Warts
  • Scabies
  • Others

Dermatoscope Market, By End User

  • Dermatology Clinics
  • Hospitals
  • Others

Dermatoscope Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Dermatoscope Market.

Available Customizations:

Global Dermatoscope Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Dermatoscope Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product (Contact Dermatoscope, Hybrid Dermatoscope, Noncontact Dermatoscope)
    • 5.2.2. By Technology (LED, Xenon, Halogen, Ultraviolet)
    • 5.2.3. By Modality (Handheld, Trolley Mounted, Headband)
    • 5.2.4. By Application (Skin Tumors, Fungal Infections, Warts, Scabies, Others)
    • 5.2.5. By End User (Dermatology Clinics, Hospitals, Others)
    • 5.2.6. By Region
    • 5.2.7. By Company (2025)
  • 5.3. Market Map

6. North America Dermatoscope Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product
    • 6.2.2. By Technology
    • 6.2.3. By Modality
    • 6.2.4. By Application
    • 6.2.5. By End User
    • 6.2.6. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Dermatoscope Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product
        • 6.3.1.2.2. By Technology
        • 6.3.1.2.3. By Modality
        • 6.3.1.2.4. By Application
        • 6.3.1.2.5. By End User
    • 6.3.2. Canada Dermatoscope Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product
        • 6.3.2.2.2. By Technology
        • 6.3.2.2.3. By Modality
        • 6.3.2.2.4. By Application
        • 6.3.2.2.5. By End User
    • 6.3.3. Mexico Dermatoscope Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product
        • 6.3.3.2.2. By Technology
        • 6.3.3.2.3. By Modality
        • 6.3.3.2.4. By Application
        • 6.3.3.2.5. By End User

7. Europe Dermatoscope Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product
    • 7.2.2. By Technology
    • 7.2.3. By Modality
    • 7.2.4. By Application
    • 7.2.5. By End User
    • 7.2.6. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Dermatoscope Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product
        • 7.3.1.2.2. By Technology
        • 7.3.1.2.3. By Modality
        • 7.3.1.2.4. By Application
        • 7.3.1.2.5. By End User
    • 7.3.2. France Dermatoscope Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product
        • 7.3.2.2.2. By Technology
        • 7.3.2.2.3. By Modality
        • 7.3.2.2.4. By Application
        • 7.3.2.2.5. By End User
    • 7.3.3. United Kingdom Dermatoscope Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product
        • 7.3.3.2.2. By Technology
        • 7.3.3.2.3. By Modality
        • 7.3.3.2.4. By Application
        • 7.3.3.2.5. By End User
    • 7.3.4. Italy Dermatoscope Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product
        • 7.3.4.2.2. By Technology
        • 7.3.4.2.3. By Modality
        • 7.3.4.2.4. By Application
        • 7.3.4.2.5. By End User
    • 7.3.5. Spain Dermatoscope Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product
        • 7.3.5.2.2. By Technology
        • 7.3.5.2.3. By Modality
        • 7.3.5.2.4. By Application
        • 7.3.5.2.5. By End User

8. Asia Pacific Dermatoscope Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product
    • 8.2.2. By Technology
    • 8.2.3. By Modality
    • 8.2.4. By Application
    • 8.2.5. By End User
    • 8.2.6. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Dermatoscope Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product
        • 8.3.1.2.2. By Technology
        • 8.3.1.2.3. By Modality
        • 8.3.1.2.4. By Application
        • 8.3.1.2.5. By End User
    • 8.3.2. India Dermatoscope Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product
        • 8.3.2.2.2. By Technology
        • 8.3.2.2.3. By Modality
        • 8.3.2.2.4. By Application
        • 8.3.2.2.5. By End User
    • 8.3.3. Japan Dermatoscope Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product
        • 8.3.3.2.2. By Technology
        • 8.3.3.2.3. By Modality
        • 8.3.3.2.4. By Application
        • 8.3.3.2.5. By End User
    • 8.3.4. South Korea Dermatoscope Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product
        • 8.3.4.2.2. By Technology
        • 8.3.4.2.3. By Modality
        • 8.3.4.2.4. By Application
        • 8.3.4.2.5. By End User
    • 8.3.5. Australia Dermatoscope Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product
        • 8.3.5.2.2. By Technology
        • 8.3.5.2.3. By Modality
        • 8.3.5.2.4. By Application
        • 8.3.5.2.5. By End User

9. Middle East & Africa Dermatoscope Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product
    • 9.2.2. By Technology
    • 9.2.3. By Modality
    • 9.2.4. By Application
    • 9.2.5. By End User
    • 9.2.6. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Dermatoscope Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product
        • 9.3.1.2.2. By Technology
        • 9.3.1.2.3. By Modality
        • 9.3.1.2.4. By Application
        • 9.3.1.2.5. By End User
    • 9.3.2. UAE Dermatoscope Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product
        • 9.3.2.2.2. By Technology
        • 9.3.2.2.3. By Modality
        • 9.3.2.2.4. By Application
        • 9.3.2.2.5. By End User
    • 9.3.3. South Africa Dermatoscope Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product
        • 9.3.3.2.2. By Technology
        • 9.3.3.2.3. By Modality
        • 9.3.3.2.4. By Application
        • 9.3.3.2.5. By End User

10. South America Dermatoscope Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product
    • 10.2.2. By Technology
    • 10.2.3. By Modality
    • 10.2.4. By Application
    • 10.2.5. By End User
    • 10.2.6. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Dermatoscope Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product
        • 10.3.1.2.2. By Technology
        • 10.3.1.2.3. By Modality
        • 10.3.1.2.4. By Application
        • 10.3.1.2.5. By End User
    • 10.3.2. Colombia Dermatoscope Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product
        • 10.3.2.2.2. By Technology
        • 10.3.2.2.3. By Modality
        • 10.3.2.2.4. By Application
        • 10.3.2.2.5. By End User
    • 10.3.3. Argentina Dermatoscope Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product
        • 10.3.3.2.2. By Technology
        • 10.3.3.2.3. By Modality
        • 10.3.3.2.4. By Application
        • 10.3.3.2.5. By End User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Dermatoscope Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Canfield Scientific, Inc.
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. FotoFinder Systems, Inc.
  • 15.3. HEINE Optotechnik GmbH & Co. KG
  • 15.4. Caliber Imaging & Diagnostics, Inc.
  • 15.5. ILLUCO Corporation Ltd.
  • 15.6. Bio-Therapeutic, Inc.
  • 15.7. Optilia Instruments AB
  • 15.8. Rudolf Riester GmbH
  • 15.9. NIDEK CO., LTD.
  • 15.10. KIRCHNER & WILHELM GmbH + Co. KG

16. Strategic Recommendations

17. About Us & Disclaimer